BODPOD-IBD
Use of Air Displacement Plethysmography to Measure Body Composition in Patients with Inflammatory Bowel Disease and Examining Associations with Disease Activity
Goals of the Network
IBD Research in Ireland
To foster collaboration and encourage multi-centre investigator initiated studies in Crohn’s Disease and Ulcerative Colitis in Ireland
Clinical Trials
To attract and facilitate industry sponsored clinical trials in Crohn’s Disease and Ulcerative Colitis in Ireland in order to improve the access for patients in Ireland to investigational drugs and therapies
Global Research Collaboration
To foster European, and Global collaboration in IBD research and improve the profile of IBD related research taking place in Ireland
Participation
To facilitate participation by Irish IBD investigators in European research consortia and networks
Investment
To attract funding for an investment in research infrastructure to support research in Crohn’s Disease and Ulcerative Colitis in Ireland
INITIative is the first collaborative research network for Inflammatory Bowel Disease in Ireland. The network is open to clinical and scientific investigators with an interest in Crohn’s Disease and Ulcerative Colitis throughout the island of Ireland.
Studies
TOAST-IBD
Treatment related Outcomes Associated with SToma in IBD: Developing core outcomes measures for intervention studies in patients with IBD who have stomas
HARP-X
Healing of Antibiotic Refractory Pouchitis with Xeljanz for those with active, chronic, antibiotic dependent or refractory pouchitis
VARIATION
Reduced serological response to COVID-19 vaccines in patients with IBD is further diminished by TNF inhibitor therapy
MOBIDIC
Molecular Biomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection study In Crohn’s disease patients
I-CARE
IBD CAncer and seRious infections in Europe
GOAL-ARC
Golimumab dose Optimisation to Adequate Levels to Achieve Response in Colitis
STEIG
Stelara Treatment Effectiveness in Irish Gastroenterology
SECURE-IBD
Surveillance Epidemiology of Coronavirus Under Research Exclusion in Inflammatory Bowel Disease